First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: May 15, 2024

Clarus Therapeutics Holdings Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clarus Therapeutics Holdings Inc
Pre-Tax Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Pre-Tax Income
-$40.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Pre-Tax Income
$20.1B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Pre-Tax Income
-$5.8B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Pre-Tax Income
-$1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Pre-Tax Income
$3.9B
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Pre-Tax Income
$7.6B
CAGR 3-Years
2%
CAGR 5-Years
20%
CAGR 10-Years
5%

See Also

What is Clarus Therapeutics Holdings Inc's Pre-Tax Income?
Pre-Tax Income
-40.6m USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Pre-Tax Income amounts to -40.6m USD.